ES2013321A6 - Un metodo de produccion de anticuerpos monoclonales - Google Patents

Un metodo de produccion de anticuerpos monoclonales

Info

Publication number
ES2013321A6
ES2013321A6 ES878701936A ES8701936A ES2013321A6 ES 2013321 A6 ES2013321 A6 ES 2013321A6 ES 878701936 A ES878701936 A ES 878701936A ES 8701936 A ES8701936 A ES 8701936A ES 2013321 A6 ES2013321 A6 ES 2013321A6
Authority
ES
Spain
Prior art keywords
monoclonal antibodies
antibodies
aeruginosaflagella
pseudomonas
bind
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES878701936A
Other languages
English (en)
Spanish (es)
Inventor
Mark E Lostrom
Anthony W Siadak
Mae Joanne Rosok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetic Systems Corp
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of ES2013321A6 publication Critical patent/ES2013321A6/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES878701936A 1986-07-03 1987-07-02 Un metodo de produccion de anticuerpos monoclonales Expired - Fee Related ES2013321A6 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15

Publications (1)

Publication Number Publication Date
ES2013321A6 true ES2013321A6 (es) 1990-05-01

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
ES878701936A Expired - Fee Related ES2013321A6 (es) 1986-07-03 1987-07-02 Un metodo de produccion de anticuerpos monoclonales

Country Status (19)

Country Link
JP (1) JP2639422B2 (nl)
KR (1) KR910002373B1 (nl)
AT (1) AT399885B (nl)
AU (1) AU615162B2 (nl)
BE (1) BE1000743A3 (nl)
CH (1) CH677796A5 (nl)
DE (1) DE3722098C2 (nl)
DK (1) DK172840B1 (nl)
ES (1) ES2013321A6 (nl)
FR (1) FR2601458B1 (nl)
GB (1) GB2192185B (nl)
IE (1) IE60888B1 (nl)
IL (1) IL83047A (nl)
IT (1) IT1221940B (nl)
LU (1) LU86938A1 (nl)
NL (1) NL194961C (nl)
OA (1) OA08629A (nl)
PT (1) PT85247B (nl)
SE (1) SE506421C2 (nl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (ja) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd ヒトモノクローナル抗体およびその製法
WO1990013033A1 (en) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
ATE188036T1 (de) * 1990-01-18 2000-01-15 Cura Nominees Pty Ltd Glykoalkaloide
EP2393515A1 (en) * 2009-02-04 2011-12-14 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
US8653242B2 (en) 2010-03-01 2014-02-18 Lostam Pharmaceuticals Ltd. Therapeutic antibodies against flagellated Pseudomonas aeruginosa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (ja) * 1984-09-26 1997-12-17 住友製薬株式会社 ヒトモノクローナル抗体およびその製法
WO1986007382A1 (en) * 1985-06-06 1986-12-18 Genetic Systems Corporation Protective human monoclonal antibodies to pseudomonas aeruginosa exotoxin a
EP0211352B1 (en) * 1985-08-01 1994-03-16 Miles Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DK172840B1 (da) * 1986-07-03 1999-08-09 Genetic Systems Corp Monoklonale antistoffer mod Pseudomonas aeruginosa flagella, farmaceutiske præparater indeholdende sådanne antistoffer og c

Also Published As

Publication number Publication date
DK336687D0 (da) 1987-06-30
NL8701554A (nl) 1988-02-01
NL194961B (nl) 2003-05-01
DK336687A (da) 1988-01-04
IE871769L (en) 1988-01-03
DE3722098A1 (de) 1988-03-03
FR2601458B1 (fr) 1992-08-21
IE60888B1 (en) 1994-08-24
BE1000743A3 (fr) 1989-03-28
OA08629A (en) 1988-11-30
IT8721163A0 (it) 1987-07-02
ATA168387A (de) 1994-12-15
KR880001815A (ko) 1988-04-27
KR910002373B1 (ko) 1991-04-20
DE3722098C2 (de) 1998-06-04
IL83047A0 (en) 1987-12-31
PT85247B (pt) 1990-06-29
JPS63102697A (ja) 1988-05-07
SE8702734D0 (sv) 1987-07-02
FR2601458A1 (fr) 1988-01-15
DK172840B1 (da) 1999-08-09
GB2192185A (en) 1988-01-06
AT399885B (de) 1995-08-25
GB8715347D0 (en) 1987-08-05
AU615162B2 (en) 1991-09-26
GB2192185B (en) 1991-01-16
LU86938A1 (fr) 1988-02-02
AU7495887A (en) 1988-01-07
IT1221940B (it) 1990-08-31
NL194961C (nl) 2003-09-02
IL83047A (en) 1992-12-01
SE506421C2 (sv) 1997-12-15
PT85247A (en) 1987-08-01
SE8702734L (sv) 1988-01-04
CH677796A5 (nl) 1991-06-28
JP2639422B2 (ja) 1997-08-13

Similar Documents

Publication Publication Date Title
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
SE8605295D0 (sv) Monoclonal antibodies cross-reactive and crossprotective against p. aeruginosa serotypes
NO2014016I2 (no) Dimetylfumarat
HUP9901144A2 (hu) Hatóanyagként klopidogrel és egy antitrombotikum új kombinációját tartalmazó gyógyszerkészítmények
IT8719081A0 (it) Complessi di bioflavonoidi con fosfolipidi, loro preparazione, uso e composizioni farmaceutici e cosmetiche.
NZ306653A (en) Isolated dna il-17 receptors
EA199800946A1 (ru) Концентрированный препарат антител
ES2062355T3 (es) Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina.
ES2009140A6 (es) Un metodo de produccion de anticuerpos monoclonales humanos de proteccion cruzada y de composiciones que los contienen.
GR3007385T3 (nl)
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
DK0845998T3 (da) Lægemidler til immunbehandling indeholdende antistoffer, der specifikt genkender MHCII-antigenet hos en patient, der skal behandles
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
ATE188873T1 (de) Tris-platin-komplexe
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DK0391185T3 (da) 1,8-Naphthyridiner
ES8707296A1 (es) Un metodo para producir anticuerpos monoclonales humanos
MD970269A (en) Clavulanates
ATE395064T1 (de) Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
AU564439B2 (en) Pharmaceutical compositions containing l-alpha- glycerylphosphorylcholine
IT8722631A0 (it) Derivati proteici del ferro altamente biodisponibile e tollerabili, loro preparazione e composizioni farmaceutiche che licontengono.
FR2707492B1 (fr) Nouvelles compositions cosmétiques ou dermatologiques renfermant les ribosomes, préparation des ribosomes, préparation desdites compositions et leur application.
EP0243174A3 (en) Monoclonal antibodies to pseudomonas aeruginosa exoenzyme s, their preparation and use
AU1507300A (en) Pharmaceutical compositions containing proteins
IE56456B1 (en) Arthritis treatment

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20070703